Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a
Anne Sophie V. M. Van den Heerik, Cathalijne C. B. Post, Marie A. D. Haverkort, Nienke Kuijsters, Stefan Kommoss, Friederike L. A. Koppe, Marlies E. Nowee, Henrike Westerveld, Maria A. A. De Jong, Filip Frühauf, Jeltsje S. Cnossen, Jan Willem M. Mens, Jannet C. Beukema, Cyrus Chargari, Charles Gillham, Dorine S. J. Tseng, Katrien Vandecasteele, Karen Verhoeven-Adema, Hans W. Nijman, Remi A. Nout, Bastiaan G. Wortman, Stephanie M. De Boer, Hein Putter, Vincent T. H. B. M Smit, Carien L. Creutzber
Springer Nature ·
2026-11-11
· DOI 10.1038/s41416-026-03642-4
Аннотация
British Journal of Cancer, Published online: 11 November 2026; doi:10.1038/s41416-026-03642-4 Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a
Anne Sophie V. M. Van den Heerik, Cathalijne C. B. Post, Marie A. D. Haverkort, Nienke Kuijsters, Stefan Kommoss, Friederike L. A. Koppe et al. Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a. // British Journal of Cancer. – 2026. – DOI: 10.1038/s41416-026-03642-4. – URL: https://www.nature.com/articles/s41416-026-03642-4
Anne Sophie V. M. Van den Heerik, Cathalijne C. B. Post, Marie A. D. Haverkort, Nienke Kuijsters, Stefan Kommoss, Friederike L. A. Koppe, Marlies E. Nowee, Henrike Westerveld, Maria A. A. De Jong, Filip Frühauf, Jeltsje S. Cnossen, Jan Willem M. Mens, Jannet C. Beukema, Cyrus Chargari, Charles Gillham, Dorine S. J. Tseng, Katrien Vandecasteele, Karen Verhoeven-Adema, Hans W. Nijman, Remi A. Nout, Bastiaan G. Wortman, Stephanie M. De Boer, Hein Putter, Vincent T. H. B. M Smit, & Carien L. Creutzber (2026). Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a. British Journal of Cancer. https://doi.org/10.1038/s41416-026-03642-4
Anne Sophie V. M. Van den Heerik, et al. “Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a.” British Journal of Cancer, 2026. doi:10.1038/s41416-026-03642-4.
@article{Heerik2026,
title = {Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a},
author = {Heerik, Anne Sophie V. M. Van den and Post, Cathalijne C. B. and Haverkort, Marie A. D. and Kuijsters, Nienke and Kommoss, Stefan and Koppe, Friederike L. A. and Nowee, Marlies E. and Westerveld, Henrike and Jong, Maria A. A. De and Frühauf, Filip and Cnossen, Jeltsje S. and Mens, Jan Willem M. and Beukema, Jannet C. and Chargari, Cyrus and Gillham, Charles and Tseng, Dorine S. J. and Vandecasteele, Katrien and Verhoeven-Adema, Karen and Nijman, Hans W. and Nout, Remi A. and Wortman, Bastiaan G. and Boer, Stephanie M. De and Putter, Hein and Smit, Vincent T. H. B. M and Creutzber, Carien L.},
journal = {British Journal of Cancer},
year = {2026},
doi = {10.1038/s41416-026-03642-4},
url = {https://www.nature.com/articles/s41416-026-03642-4}
}